Rebus Holdings Inc (RBSH)

[MoMoney4me1]

$NSPX Inspyr has strategically expanded its portfolio to include 15 issued U.S. #patents and more than 40 pending applications worldwide, focused on the U.S., Europe, and Asia Pacific. #treatments Inspyr Therapeutics (@InspyrTheraputx)

Inspyr has strategically expanded its portfolio to include 15 issued U.S. #patents and more than 40 pending applications worldwide, focused on the U.S., Europe, and Asia Pacific. #cancer #treatments https://t.co/KUYFY368oT

— Inspyr Therapeutics (@InspyrTheraputx) February 25, 2020

February 25, 2020